We provide you with 20 years of free, institutional-grade data for TXG stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TXG. Explore the full financial landscape of TXG stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-08 | 0001770787 | TXG | 10-Q | Url |
| 2025-05-09 | 0001770787 | TXG | 10-Q | Url |
| 2025-02-13 | 0001770787 | TXG | 10-K | Url |
| 2024-10-29 | 0001770787 | TXG | 10-Q | Url |
| 2024-08-08 | 0001770787 | TXG | 10-Q | Url |
| 2024-04-30 | 0001770787 | TXG | 10-Q | Url |
| 2024-02-15 | 0001770787 | TXG | 10-K | Url |
| 2023-11-03 | 0001770787 | TXG | 10-Q | Url |
| 2023-08-04 | 0001770787 | TXG | 10-Q | Url |
| 2023-05-04 | 0001770787 | TXG | 10-Q | Url |
| 2023-02-16 | 0001770787 | TXG | 10-K | Url |
| 2022-11-03 | 0001770787 | TXG | 10-Q | Url |
| 2022-08-09 | 0001770787 | TXG | 10-Q | Url |
| 2022-05-05 | 0001770787 | TXG | 10-Q | Url |
| 2022-02-18 | 0001770787 | TXG | 10-K | Url |
| 2021-11-05 | 0001770787 | TXG | 10-Q | Url |
| 2021-08-06 | 0001770787 | TXG | 10-Q | Url |
| 2021-05-07 | 0001770787 | TXG | 10-Q | Url |
| 2021-02-26 | 0001770787 | TXG | 10-K | Url |
| 2020-11-12 | 0001770787 | TXG | 10-Q | Url |
| 2020-09-08 | 0001770787 | TXG | S-1 | Url |
| 2020-08-12 | 0001770787 | TXG | 10-Q | Url |
| 2020-05-12 | 0001770787 | TXG | 10-Q | Url |
| 2020-02-27 | 0001770787 | TXG | 10-K | Url |
| 2019-11-12 | 0001770787 | TXG | 10-Q | Url |
| 2019-08-19 | 0001770787 | TXG | S-1 | Url |
10x Genomics, Inc(NASDAQ:TXG) 
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluid...
Website: http://www.10xgenomics.com
Founded: 2012
IPO Price: $39 (Sep 12, 2019)
Full Time Employees: 1,243 (Dec 2022)
Founder: Serge Saxonov, Ben Hindson, Kevin Ness
CEO: Serge Saxonov
Sector: Healthcare
Industry: Health Information Services
The information provided in this report about TXG stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.